MXCT
MaxCyte, Inc. · Healthcare
Director John Joseph Johnston sold $67K of MaxCyte, Inc.
Sold$66,603
$4.44Price
15,000Shares
−11%Stake
What MXCT did after the filing
- The stock from Wed, Jun 28 close, $4.54
- −14.0%
- S&P 500, same days
- +2.2%
Measured over 30 trading days, to the Aug 10 close.
Traded Mon, Jun 26. Filed Wed, Jun 28, 1:05 PM ET, during the session. Returns use the Jun 28 close and the Aug 10 close. Not investment advice.